BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32276567)

  • 1. A series of molecular modeling techniques to reveal selective mechanisms of inhibitors to β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) and β-site amyloid precursor protein cleaving enzyme 2 (BACE2).
    Li S; Zhao H; Li J; Hao J; Yu H
    J Biomol Struct Dyn; 2021 May; 39(8):2824-2837. PubMed ID: 32276567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanism of Binding Selectivity of Inhibitors toward BACE1 and BACE2 Revealed by Multiple Short Molecular Dynamics Simulations and Free-Energy Predictions.
    Chen J; Wang J; Yin B; Pang L; Wang W; Zhu W
    ACS Chem Neurosci; 2019 Oct; 10(10):4303-4318. PubMed ID: 31545898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2.
    Fujimoto K; Matsuoka E; Asada N; Tadano G; Yamamoto T; Nakahara K; Fuchino K; Ito H; Kanegawa N; Moechars D; Gijsen HJM; Kusakabe KI
    J Med Chem; 2019 May; 62(10):5080-5095. PubMed ID: 31021626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Highly Selective BACE1 Inhibitors and Their Effects on Dendritic Spine Density In Vivo.
    Pratsch K; Unemura C; Ito M; Lichtenthaler SF; Horiguchi N; Herms J
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2.
    Pettus LH; Bourbeau MP; Bradley J; Bartberger MD; Chen K; Hickman D; Johnson M; Liu Q; Manning JR; Nanez A; Siegmund AC; Wen PH; Whittington DA; Allen JR; Wood S
    J Med Chem; 2020 Mar; 63(5):2263-2281. PubMed ID: 31589043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations.
    Hernández-Rodríguez M; Correa-Basurto J; Gutiérrez A; Vitorica J; Rosales-Hernández MC
    Eur J Med Chem; 2016 Nov; 124():1142-1154. PubMed ID: 27639619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.
    Sun X; Wang Y; Qing H; Christensen MA; Liu Y; Zhou W; Tong Y; Xiao C; Huang Y; Zhang S; Liu X; Song W
    FASEB J; 2005 May; 19(7):739-49. PubMed ID: 15857888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease.
    Jeppsson F; Eketjäll S; Janson J; Karlström S; Gustavsson S; Olsson LL; Radesäter AC; Ploeger B; Cebers G; Kolmodin K; Swahn BM; von Berg S; Bueters T; Fälting J
    J Biol Chem; 2012 Nov; 287(49):41245-57. PubMed ID: 23048024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of intermolecular interactions and stability of verubecestat in the active site of BACE1: Development of first model from QM/MM-based charge density and MD analysis.
    Saravanan K; Sivanandam M; Hunday G; Mathiyalagan L; Kumaradhas P
    J Biomol Struct Dyn; 2019 Jun; 37(9):2339-2354. PubMed ID: 30044206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and molecular insights into tacrine-benzofuran hybrid induced inhibition of amyloid-β peptide aggregation and BACE1 activity.
    Kaur R; Narang SS; Singh P; Goyal B
    J Biomol Struct Dyn; 2023; 41(22):13211-13227. PubMed ID: 37013977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Disulfide Bonds on Binding of Inhibitors to β-Amyloid Cleaving Enzyme 1 Decoded by Multiple Replica Accelerated Molecular Dynamics Simulations.
    Chen J; Yin B; Wang W; Sun H
    ACS Chem Neurosci; 2020 Jun; 11(12):1811-1826. PubMed ID: 32459964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility.
    Kumalo HM; Soliman ME
    J Recept Signal Transduct Res; 2016 Oct; 36(5):505-14. PubMed ID: 26804314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACE1 and BACE2 enzymatic activities in Alzheimer's disease.
    Ahmed RR; Holler CJ; Webb RL; Li F; Beckett TL; Murphy MP
    J Neurochem; 2010 Feb; 112(4):1045-53. PubMed ID: 19968762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice.
    Shimshek DR; Jacobson LH; Kolly C; Zamurovic N; Balavenkatraman KK; Morawiec L; Kreutzer R; Schelle J; Jucker M; Bertschi B; Theil D; Heier A; Bigot K; Beltz K; Machauer R; Brzak I; Perrot L; Neumann U
    Sci Rep; 2016 Feb; 6():21917. PubMed ID: 26912421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Extremely Selective Fused Pyridine-Derived β-Site Amyloid Precursor Protein-Cleaving Enzyme (BACE1) Inhibitors with High In Vivo Efficacy through 10s Loop Interactions.
    Ueno T; Matsuoka E; Asada N; Yamamoto S; Kanegawa N; Ito M; Ito H; Moechars D; Rombouts FJR; Gijsen HJM; Kusakabe KI
    J Med Chem; 2021 Oct; 64(19):14165-14174. PubMed ID: 34553947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2.
    Fujimoto K; Yoshida S; Tadano G; Asada N; Fuchino K; Suzuki S; Matsuoka E; Yamamoto T; Yamamoto S; Ando S; Kanegawa N; Tonomura Y; Ito H; Moechars D; Rombouts FJR; Gijsen HJM; Kusakabe KI
    J Med Chem; 2021 Mar; 64(6):3075-3085. PubMed ID: 33719429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective BACE1 inhibitor VIa reduces amyloid-β production in cell and mouse models of Alzheimer's disease.
    Cheng X; Zhou Y; Gu W; Wu J; Nie A; Cheng J; Zhou J; Zhou W; Zhang Y
    J Alzheimers Dis; 2013; 37(4):823-34. PubMed ID: 23948917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACE2 degradation mediated by the macroautophagy-lysosome pathway.
    Liu X; Wang Z; Wu Y; Wang J; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1970-7. PubMed ID: 23773066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Selective and Potent Human β-Secretase 2 (BACE2) Inhibitors against Type 2 Diabetes: Design, Synthesis, X-ray Structure and Structure-Activity Relationship Studies.
    Ghosh AK; Brindisi M; Yen YC; Lendy EK; Kovela S; Cárdenas EL; Reddy BS; Rao KV; Downs D; Huang X; Tang J; Mesecar AD
    ChemMedChem; 2019 Mar; 14(5):545-560. PubMed ID: 30637955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020).
    Rombouts F; Kusakabe KI; Hsiao CC; Gijsen HJM
    Expert Opin Ther Pat; 2021 Jan; 31(1):25-52. PubMed ID: 33006491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.